Acceleron pharma inc (XLRN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12
Revenues

75,557

73,993

38,470

37,520

13,539

13,991

13,880

13,636

13,008

13,481

13,146

13,137

13,275

27,771

28,206

29,356

31,878

18,097

18,031

17,384

15,745

14,632

22,414

23,176

45,525

57,230

49,614

0

0

0

Costs and expenses:
Research and Development Expense

158,845

153,953

135,037

122,074

113,242

103,902

99,373

95,765

91,430

89,726

83,478

79,521

74,061

68,580

65,626

61,859

59,871

58,404

56,843

55,384

53,911

50,897

46,535

42,802

39,036

36,051

34,556

0

0

0

Selling, general and administrative

63,924

56,485

51,103

44,255

37,876

34,503

30,751

29,631

33,343

33,738

33,002

31,880

27,222

25,297

24,812

23,834

21,783

20,572

18,508

16,098

15,149

14,199

15,240

15,228

14,881

14,227

11,513

0

0

0

Litigation settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

Total costs and expenses

222,769

210,438

186,140

166,329

151,118

138,405

130,124

125,396

124,773

123,464

116,480

111,401

101,283

93,877

90,438

85,693

81,654

78,976

75,351

71,482

74,060

70,096

66,775

63,030

53,917

50,278

46,069

0

0

0

Loss from operations

-147,212

-136,445

-147,670

-128,809

-137,579

-124,414

-116,244

-111,760

-111,765

-109,983

-103,334

-98,264

-88,008

-66,106

-62,232

-56,337

-49,776

-60,879

-57,320

-54,098

-58,315

-55,464

-44,361

-39,854

-8,392

6,952

3,545

0

0

0

Other income (expense):
Other income (expense), net

-

-

-

-

-

-

-

-

-

-992

1,554

1,170

-1,466

7,262

-4,097

-687

4,734

-3,527

2,508

3,286

1,469

5,044

-6,096

-20,639

-21,734

-26,797

-12,438

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

2,553

1,979

1,995

2,022

1,854

1,505

1,132

783

512

380

266

133

83

73

53

40

39

47

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

922

1,368

1,853

2,579

2,092

2,157

0

0

0

Other income, net

9,401

11,525

11,557

9,108

6,857

5,516

4,251

3,266

2,535

1,561

0

0

0

-

0

0

-

-3,015

2,888

3,552

1,602

4,205

-7,391

-22,439

-24,273

-28,850

-14,548

0

0

0

Loss before income taxes

-137,811

-124,920

-136,113

-119,701

-130,722

-118,898

-111,993

-108,494

-109,230

-108,422

-99,801

-95,099

-87,452

-56,990

-49,603

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Income tax provision

-67

-62

-94

-72

-17

-27

70

41

36

32

15

36

30

24

-20

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-137,744

-124,858

-136,019

-119,629

-130,705

-118,871

-112,063

-108,535

-109,266

-108,454

-99,816

-95,135

-87,482

-57,014

-64,804

-55,892

-44,259

-63,894

-54,432

-50,546

-56,713

-51,259

0

0

0

-

-

-

0

0

Net loss applicable to participating securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Net loss applicable to common stockholdersbasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Net income (loss) per share applicable to common stockholders:
Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.14

-

-

-

-0.45

-

-

-

-

-

-5.62

0.30

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.13

-

-

-

-0.45

-

-

-

-

-

-5.62

0.28

-

-

Weighted-average number of common shares used in computing net loss per share applicable to common stockholders:
Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,911

-

-

-

32,633

-

-

-

-

-

4,406

2,438

-

-

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,666

-

-

-

32,633

-

-

-

-

-

4,406

4,457

-

-

Other comprehensive (loss) income:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

Accretion of dividends, interest, redemption value and issuance costs on redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,870

26,618

0

0

0

Gain on extinguishment of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,765

0

0

0

-

Net loss applicable to participating securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Net (loss) income applicable to common stockholders-basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-39,003

0

0

0

-

Net (loss) income

-137,744

-124,858

-136,019

-119,629

-130,705

-118,871

-112,063

-108,535

-109,266

-108,454

-99,816

-95,135

-87,482

-57,014

-64,804

-55,892

-44,259

-63,894

0

0

0

-

0

0

0

-

-

-

0

0

Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax

48

583

895

1,204

1,032

335

-510

-690

-924

-470

-132

-606

-425

-205

-101

314

68

-220

-21

-62

-43

0

0

0

0

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

Comprehensive loss

-137,696

-124,275

-135,124

-118,425

-129,673

-118,536

-112,573

-109,225

-110,190

-108,924

-99,948

-95,741

-87,907

-57,219

-64,905

-55,578

-44,191

-64,114

-54,453

-50,608

-56,756

-51,259

-51,752

-62,293

-32,665

-21,898

-11,003

0

0

0

Net loss per share- basic and diluted (in dollars per share)

-0.95

-0.44

-0.86

-0.34

-0.74

-0.75

-0.63

-0.63

-0.58

-0.60

-0.65

-0.77

-0.66

-

-0.55

-0.59

-

-

-0.36

-0.32

-

-0.56

-0.25

-0.52

-0.30

-

-

-

-0.24

-5.82

Weighted-average number of common shares used in computing net loss per share- basic and diluted (in shares)

53,361

53,115

52,882

52,689

51,126

46,236

46,051

45,789

45,516

45,284

39,361

38,631

38,404

-

37,616

37,272

-

-

33,097

32,870

-

32,332

31,855

31,552

30,321

-

-

-

9,740

2,400

License and milestone
Revenue

-

-

0

0

-

-

0

0

-

541

540

540

540

15,549

15,591

15,661

15,957

1,184

1,379

1,454

1,370

1,673

9,205

9,563

32,107

43,948

38,505

0

0

0

Cost-sharing, net
Revenues

14,037

13,993

13,470

12,520

13,539

13,991

0

13,365

12,602

12,940

12,605

12,596

12,734

12,221

12,615

13,695

15,921

16,913

16,652

15,930

14,375

12,959

13,209

13,613

13,418

13,282

11,109

0

0

0

Royalty
Revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-